HRP20090146T3 - Kamptotecini konjugirani na položaju 7 s cikličkim peptidima kao citostatska sredstva - Google Patents

Kamptotecini konjugirani na položaju 7 s cikličkim peptidima kao citostatska sredstva

Info

Publication number
HRP20090146T3
HRP20090146T3 HR20090146T HRP20090146T HRP20090146T3 HR P20090146 T3 HRP20090146 T3 HR P20090146T3 HR 20090146 T HR20090146 T HR 20090146T HR P20090146 T HRP20090146 T HR P20090146T HR P20090146 T3 HRP20090146 T3 HR P20090146T3
Authority
HR
Croatia
Prior art keywords
group
branched
linear
alkylene
alkyl
Prior art date
Application number
HR20090146T
Other languages
English (en)
Croatian (hr)
Inventor
Del Pozzo Alma
Penco Sergio
Merlini Lucio
Giannini Giuseppe
Ornella Tinti Maria
Pisano Claudio
Zunino Franco
Alloatti Domenico
Vesci Loredana
Dallavalle Sabrina
Ming Hong Ni
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A., Istituto Nazionale Per Lo Studio E La Cura Dei Tumori filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of HRP20090146T3 publication Critical patent/HRP20090146T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR20090146T 2004-05-13 2005-05-04 Kamptotecini konjugirani na položaju 7 s cikličkim peptidima kao citostatska sredstva HRP20090146T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000240A ITRM20040240A1 (it) 2004-05-13 2004-05-13 Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
PCT/IT2005/000260 WO2005111063A1 (en) 2004-05-13 2005-05-04 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents

Publications (1)

Publication Number Publication Date
HRP20090146T3 true HRP20090146T3 (hr) 2009-05-31

Family

ID=34968014

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090146T HRP20090146T3 (hr) 2004-05-13 2005-05-04 Kamptotecini konjugirani na položaju 7 s cikličkim peptidima kao citostatska sredstva

Country Status (23)

Country Link
US (1) US7705012B2 (enExample)
EP (1) EP1753776B1 (enExample)
JP (1) JP4805917B2 (enExample)
KR (1) KR101145815B1 (enExample)
CN (1) CN1953989B (enExample)
AR (1) AR048949A1 (enExample)
AT (1) ATE420891T1 (enExample)
AU (1) AU2005243417B2 (enExample)
BR (1) BRPI0510983A (enExample)
CA (1) CA2563708A1 (enExample)
CY (1) CY1108985T1 (enExample)
DE (1) DE602005012390D1 (enExample)
DK (1) DK1753776T3 (enExample)
ES (1) ES2321114T3 (enExample)
HR (1) HRP20090146T3 (enExample)
IT (1) ITRM20040240A1 (enExample)
MX (1) MXPA06012884A (enExample)
PL (1) PL1753776T3 (enExample)
PT (1) PT1753776E (enExample)
RS (1) RS51169B (enExample)
SI (1) SI1753776T1 (enExample)
TW (1) TWI352703B (enExample)
WO (1) WO2005111063A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
WO2008098701A1 (en) * 2007-02-13 2008-08-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
TW201004647A (en) * 2008-05-20 2010-02-01 Sigma Tau Ind Farmaceuti Novel dual targeting antitumoural conjugates
WO2011002852A2 (en) * 2009-06-30 2011-01-06 The Regents Of The University Of Michigan Pro-drug complexes and related methods of use
WO2011079015A1 (en) * 2009-12-21 2011-06-30 The Regents Of The University Of California Rgd-containing cyclic peptides
WO2011100688A1 (en) 2010-02-12 2011-08-18 Dana-Farber Cancer Institute, Inc. Improved antagonists of muc1
US20130101664A1 (en) 2011-08-18 2013-04-25 Donald W. Kufe Muc1 ligand traps for use in treating cancers
CN102516258B (zh) * 2011-11-11 2014-06-25 正大天晴药业集团股份有限公司 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用
US9044421B2 (en) 2012-03-28 2015-06-02 Genus Oncology, Llc Treating MUC1-expressing cancers with combination therapies
US10420845B2 (en) 2015-06-18 2019-09-24 Ramot At Tel-Aviv University Ltd. Taggable heteroaromatic drugs and conjugates thereof
US10494403B2 (en) * 2018-03-06 2019-12-03 Ciphore Biomed Technology Limited Company Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same
CN115590975A (zh) * 2022-11-15 2023-01-13 无锡福祈制药有限公司（Cn） 丝裂霉素-rgd肽偶联物及其制备方法
CN120078902A (zh) * 2023-12-01 2025-06-03 深圳碳云智肽药物科技有限公司 一种多肽偶联喜树碱衍生物及其抗肿瘤应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE136898T1 (de) * 1991-10-29 1996-05-15 Glaxo Wellcome Inc Wasserlösliche camptothecinderivate
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
CA2192725C (en) 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
AU6272598A (en) * 1997-02-14 1998-09-08 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
DE19815812A1 (de) 1998-04-08 1999-10-14 Bayer Ag Modifizierte Cytostatika
EP1044977B1 (en) 1999-03-09 2002-05-02 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity
JP2003508497A (ja) * 1999-09-08 2003-03-04 バイエル アクチェンゲゼルシャフト インテグリンに媒介される薬物ターゲッティング
EP1373501A2 (en) * 2000-10-06 2004-01-02 Novartis AG Targeting molecules for adenoviral vectors
WO2002096367A2 (en) * 2001-05-30 2002-12-05 Targesome, Inc. Targeted multivalent macromolecules

Also Published As

Publication number Publication date
AR048949A1 (es) 2006-06-14
TW200606165A (en) 2006-02-16
EP1753776A1 (en) 2007-02-21
CY1108985T1 (el) 2014-07-02
KR20070012530A (ko) 2007-01-25
DK1753776T3 (da) 2009-05-11
US20080033003A1 (en) 2008-02-07
AU2005243417A2 (en) 2005-11-24
DE602005012390D1 (de) 2009-03-05
BRPI0510983A (pt) 2007-12-04
US7705012B2 (en) 2010-04-27
TWI352703B (en) 2011-11-21
SI1753776T1 (sl) 2009-06-30
PL1753776T3 (pl) 2009-06-30
ATE420891T1 (de) 2009-01-15
AU2005243417B2 (en) 2011-07-07
CN1953989B (zh) 2012-10-10
KR101145815B1 (ko) 2012-05-16
EP1753776B1 (en) 2009-01-14
ITRM20040240A1 (it) 2004-08-13
MXPA06012884A (es) 2007-02-15
WO2005111063A1 (en) 2005-11-24
ES2321114T3 (es) 2009-06-02
PT1753776E (pt) 2009-03-05
CN1953989A (zh) 2007-04-25
AU2005243417A1 (en) 2005-11-24
JP2008504235A (ja) 2008-02-14
CA2563708A1 (en) 2005-11-24
JP4805917B2 (ja) 2011-11-02
RS51169B (sr) 2010-10-31

Similar Documents

Publication Publication Date Title
CO5130007A1 (es) Derivados glicol de xantinas y composiciones farmaceuticas que contienen dichos compuestos
BR0114994A (pt) Composição de vacina
ES2084808T3 (es) Uso de un fosfato de un alfa-tocoferol, o de uno de sus derivados para la preparacion de composiciones cosmeticas, dermatologicas, o farmaceuticas; composiciones asi obtenidas.
DE69110136D1 (de) Kaffeinsaure-derivate,oraposid,ihre kosmetische oder pharmazeutische zusammensetzungen,insbesondere mit dermatologischer wirkung.
AR035365A1 (es) Compuesto peptidico que comprende un centro inhibidor de la metionina aminopeptidasa 2 (metap-2) y su uso para preparar un medicamento
DE59102997D1 (de) Chirurgische Klammer.
ES2262769T3 (es) Utilizacion de un compuesto de poliguanidina para el tratamiento o peinado del cabello, especialmente el alisado o la permanente.
BRPI0900985A2 (pt) utilização de uma composição cosmética e processo de tratamento cosmético das fibras queratìnicas
AR035016A1 (es) Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
DK1233784T3 (da) Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering
BR0114986A (pt) Composto, composição farmacêutica, uso de pelo menos um composto ou um sal, solvato ou hidrato deste farmaceuticamente aceitáveis, e, processo para preparar triazolona partir de uma acil semicarbazida.
BRPI0313477B8 (pt) derivados de purina, composição farmacêutica que os compreende, seu processo de preparação e uso
PT99667A (pt) Processo de preparacao de nonapeptidos antagonistas da bombesina e de composicoes farmaceuticas que os contem
PE20020992A1 (es) Conjugados peg de hgf-nk4
ES2618520T3 (es) Pirrolocarboxamidas sustituidas con fluorometilo
ES2062706T3 (es) Nuevos derivados de amino-metil-piperidina su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR048949A1 (es) Camptotecina conjugada en posicion 7 con antagonistas de la integrina
TR199802384T2 (xx) N�rodejeneratif hastal�klar�n tedavisinde yararl� farmas�tik bile�imlerin haz�rlanmas� i�in P-Aminofenol t�revlerinin kullan�m�.
JP2008504235A5 (enExample)
DE69840781D1 (de) 2-Chlor-6-Methyl-3-Aminophenol und eine Oxidationsbase enthaltende Zusammensetzung zur oxidativen Färbung von Keratinfasern und Färbeverfahren
BR9807407A (pt) Processo para fabricar uma composição de limpeza aquosa tendo melhorada estabilidade de espuma, e , composição de limpeza aquosa
HRP20080330T3 (en) Antitumoral compounds based on kahalalide f
DE69924963D1 (de) Kosmetische Aufhellung mit einem Hydroxyphenyloxim-Derivat
AR049275A1 (es) Derivados de camptotecina conjugada en posicion 20 con antagonistas de la integrina
EA200101103A1 (ru) НОВЫЕ 15-ЧЛЕННЫЕ 8а- И 9а ЛАКТАМЫ